ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases)

ClinicalTrials.gov ID: NCT00549757

Public ClinicalTrials.gov record NCT00549757. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 11:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Determine Whether, in Patients With Type 2 Diabetes at High Risk for Cardiovascular and Renal Events, Aliskiren, on Top of Conventional Treatment, Reduces Cardiovascular and Renal Morbidity and Mortality

Study identification

NCT ID
NCT00549757
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
8,606 participants

Conditions and interventions

Interventions

  • Aliskiren Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
35 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2007
Primary completion
Jan 31, 2013
Completion
Jan 31, 2013
Last update posted
Apr 20, 2014

2007 – 2013

United States locations

U.S. sites
118
U.S. states
36
U.S. cities
102
Facility City State ZIP Site status
Novartis Investigative Site Birmingham Alabama 35209
Novartis Investigative Site Birmingham Alabama 35235
Novartis Investigative Site Huntsville Alabama 35801
Novartis Investigative Site Mobile Alabama 36608
Novartis Investigative Site Mobile Alabama 36617
Novartis Investigative Site Montgomery Alabama 36106
Novartis Investigative Site Muscle Shoals Alabama 35662
Novartis Investigative Site Peoria Arizona 85381
Novartis Investigative Site Phoenix Arizona 85032
Novartis Investigative Site Tucson Arizona 85712
Novartis Investigative Site Tucson Arizona 85741
Novartis Investigative Site Fayetteville Arkansas 72703
Novartis Investigative Site Burlingame California 94010
Novartis Investigative Site Fullerton California 92835
Novartis Investigative Site Huntington Beach California 92648
Novartis Investigative Site Oakland California 94609
Novartis Investigative Site Pasadena California 91101
Novartis Investigative Site Riverside California 92501
Novartis Investigative Site Spring Valley California 91978-1522
Novartis Investigative Site Torrance California 90502
Novartis Investigative Site Walnut Creek California 94598
Novartis Investigative Site Denver Colorado 80209
Novartis Investigative Site Bridgeport Connecticut 06610
Novartis Investigative Site Aventura Florida 33180
Novartis Investigative Site Boca Raton Florida 33433
Novartis Investigative Site Fort Lauderdale Florida 33311
Novartis Investigative Site Hollywood Florida 33021
Novartis Investigative Site Jacksonville Florida 32204
Novartis Investigative Site Jacksonville Florida 32205
Novartis Investigative Site Jacksonville Florida 32209
Novartis Investigative Site Jacksonville Florida 32216
Novartis Investigative Site Lauderdale Lakes Florida 33313
Novartis Investigative Site Pensacola Florida 32504
Novartis Investigative Site Plantation Florida 33324
Novartis Investigative Site West Palm Beach Florida 33401
Novartis Investigative Site Atlanta Georgia 30309
Novartis Investigative Site Augusta Georgia 30904
Novartis Investigative Site Augusta Georgia 30909
Novartis Investigative Site Cumming Georgia 30041
Novartis Investigative Site Honolulu Hawaii 96813
Novartis Investigative Site Honolulu Hawaii 96814
Novartis Investigative Site Champaign Illinois 61820
Novartis Investigative Site Lake Zurich Illinois 60047
Novartis Investigative Site Peoria Illinois 61615
Novartis Investigative Site Topeka Kansas 66606
Novartis Investigative Site Louisville Kentucky 40202
Novartis Investigative Site Metairie Louisiana 70006
Novartis Investigative Site Slidell Louisiana 70458
Novartis Investigative Site Baltimore Maryland 21204
Novartis Investigative Site Burlington Massachusetts 01803
Novartis Investigative Site Haverhill Massachusetts 01830
Novartis Investigative Site Jamaica Plain Massachusetts 02130
Novartis Investigative Site Natick Massachusetts 01760
Novartis Investigative Site North Dartmouth Massachusetts 02747
Novartis Investigative Site Waltham Massachusetts 02154
Novartis Investigative Site Worcester Massachusetts 01609
Novartis Investigative Site Ann Arbor Michigan 48109
Novartis Investigative Site Detroit Michigan 48202
Novartis Investigative Site Detroit Michigan 48236
Novartis Investigative Site Kalamazoo Michigan 49048
Novartis Investigative Site Livonia Michigan 48154
Novartis Investigative Site Minneapolis Minnesota 55404
Novartis Investigative Site Minneapolis Minnesota 55455
Novartis Investigative Site Saint Louis Park Minnesota 55416
Novartis Investigative Site Belzoni Mississippi 39038
Novartis Investigative Site Gulfport Mississippi 39501
Novartis Investigative Site Jackson Mississippi 39209
Novartis Investigative Site Springfield Missouri 65807
Novartis Investigative Site St Louis Missouri 63110-1093
Novartis Investigative Site St Louis Missouri 63141
Novartis Investigative Site Fremont Nebraska 68025
Novartis Investigative Site Omaha Nebraska 68131
Novartis Investigative Site Dover New Hampshire 03820-2403
Novartis Investigative Site Princeton Junction New Jersey 08550
Novartis Investigative Site Albuquerque New Mexico 87106
Novartis Investigative Site Albany New York 12206
Novartis Investigative Site Rochester New York 14607
Novartis Investigative Site Cincinnati Ohio 45236
Novartis Investigative Site Cleveland Ohio 44115
Novartis Investigative Site Lyndhurst Ohio 44124
Novartis Investigative Site Norman Oklahoma 73069
Novartis Investigative Site Oklahoma City Oklahoma 73112
Novartis Investigative Site Tulsa Oklahoma 74133
Novartis Investigative Site Allentown Pennsylvania 18103
Novartis Investigative Site Lancaster Pennsylvania 17604
Novartis Investigative Site Lansdale Pennsylvania 19446
Novartis Investigative Site Melrose Park Pennsylvania 19027
Novartis Investigative Site Philadelphia Pennsylvania 19138
Novartis Investigative Site Wyomissing Pennsylvania 19610
Novartis Investigative Site Warwick Rhode Island 02886
Novartis Investigative Site Aiken South Carolina 29801
Novartis Investigative Site Charleston South Carolina 29425
Novartis Investigative Site Columbia South Carolina 29201
Novartis Investigative Site Greenville South Carolina 29605
Novartis Investigative Site Orangeburg South Carolina 29115
Novartis Investigative Site Collierville Tennessee 38017
Novartis Investigative Site Amarillo Texas 79106
Novartis Investigative Site Austin Texas 78731
Novartis Investigative Site Dallas Texas 75226
Novartis Investigative Site Dallas Texas 75231
Novartis Investigative Site Dallas Texas 75235
Novartis Investigative Site Dallas Texas 75390
Novartis Investigative Site Houston Texas 77030
Novartis Investigative Site Irving Texas 75039
Novartis Investigative Site McAllen Texas 78501
Novartis Investigative Site North Richland Hills Texas 76180
Novartis Investigative Site Plano Texas 75024
Novartis Investigative Site San Antonio Texas 78207
Novartis Investigative Site San Antonio Texas 78218
Novartis Investigative Site San Antonio Texas 78229-4801
Novartis Investigative Site Temple Texas 76508-0002
Novartis Investigative Site Bennington Vermont 05201
Novartis Investigative Site Burlington Vermont 05401
Novartis Investigative Site Alexandria Virginia 22304-2315
Novartis Investigative Site Burke Virginia 22015
Novartis Investigative Site Renton Washington 98055
Novartis Investigative Site Charleston West Virginia 25301
Novartis Investigative Site Appleton Wisconsin 54911

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 658 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00549757, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 20, 2014 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00549757 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →